Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanism of biased signaling at the kappa opioid receptor
Amal El Daibani, Joseph M. Paggi, Kuglae Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The Art and Science of Molecular Docking
Joseph M. Paggi, Ayush Pandit, Ron O. Dror
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 389-410
Closed Access | Times Cited: 64
Ligand efficacy modulates conformational dynamics of the µ-opioid receptor
Jiawei Zhao, Matthias Elgeti, Evan S. O’Brien, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 474-480
Open Access | Times Cited: 21
Computational drug development for membrane protein targets
Haijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 229-242
Closed Access | Times Cited: 16
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
Mario García‐Domínguez
Biomedicines (2025) Vol. 13, Iss. 1, pp. 165-165
Open Access | Times Cited: 2
Molecular basis of opioid receptor signaling
Tao Che, Bryan L. Roth
Cell (2023) Vol. 186, Iss. 24, pp. 5203-5219
Open Access | Times Cited: 38
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
Terry Kenakin
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 626-644
Closed Access | Times Cited: 8
IUPHAR themed review: Opioid efficacy, bias, and selectivity
Nokomis Ramos‐Gonzalez, Barnali Paul, Susruta Majumdar
Pharmacological Research (2023) Vol. 197, pp. 106961-106961
Open Access | Times Cited: 18
Bias translation: The final frontier?
Terry Kenakin
British Journal of Pharmacology (2024) Vol. 181, Iss. 9, pp. 1345-1360
Open Access | Times Cited: 8
Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor
Andrew J. Y. Jones, Thomas H. Harman, Matthew Harris, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 5
Flavors of GPCR signaling bias
Mohammad Seyedabadi, Vsevolod V. Gurevich
Neuropharmacology (2024), pp. 110167-110167
Closed Access | Times Cited: 5
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy
Thomas O. Schrader, Kym I. Lorrain, Didier Bagnol, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 685-698
Closed Access | Times Cited: 4
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects
Seth F. Vigneron, Shohei Ohno, João Braz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects
Ross van de Wetering, Loan Y. Vu, Lindsay Kornberger, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 604-604
Open Access
How Ligands Achieve Biased Signaling toward Arrestins
Qianru Jiang, Tao Che
Biochemistry (2025)
Closed Access
Synchrony between midbrain gene transcription and dopamine terminal regulation is modulated by chronic alcohol drinking
Zahra Z. Farahbakhsh, Katherine M. Holleran, Jonathon Sens, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches
Shaima Hashem, Alexis Dougha, Pierre Tufféry
Molecules (2025) Vol. 30, Iss. 5, pp. 1047-1047
Open Access
Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists–Inverse Agonists with Reduced Withdrawal Effects
Seth F. Vigneron, Shohei Ohno, Joao Bráz, et al.
ACS Central Science (2025)
Open Access
Progress on the development of Class A GPCR‐biased ligands
Paula Morales, Magdalena M. Scharf, Marcel Bermúdez, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies.
Aurélien Fouillen, Pierre Couvineau, Gérald Gaibelet, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3784-3799
Open Access | Times Cited: 3
Biased Signaling in Mutated Variants of β2-Adrenergic Receptor: Insights from Molecular Dynamics Simulations
Midhun K. Madhu, Kunal Shewani, Rajesh K. Murarka
Journal of Chemical Information and Modeling (2024)
Closed Access | Times Cited: 2
Morphinan Evolution: The Impact of Advances in Biochemistry and Molecular Biology
Keita Kajino, Akihisa Tokuda, Tsuyoshi Saitoh
The Journal of Biochemistry (2024) Vol. 175, Iss. 4, pp. 337-355
Open Access | Times Cited: 2
Structural and Dynamic Insights into the Biased Signaling Mechanism of the Human Kappa Opioid Receptor
Chiyo Suno-Ikeda, Ryo Nishikawa, Riko Suzuki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Discovery of an Ortho-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect
Zixiang Li, Ru-Feng Ye, He Qian, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7112-7129
Closed Access | Times Cited: 2
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Marie Emilie Hovah, Ulrike Holzgrabe
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2545-2599
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top